Matches in SemOpenAlex for { <https://semopenalex.org/work/W1596286866> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W1596286866 abstract "Uveal melanoma (UM) represents the most common intraocular malignancy, and there are no effective treatments for this aggressive disease. Nearly 80% of UM is characterized by oncogenic mutations in G protein subunits Gnaq and Gna11, and 70% have extra copies of the oncogene MYC. Chromatin regulators have become attractive targets for cancer therapy. In particular, the BET-bromodomain inhibitor JQ1 has shown selective inhibition of c-Myc expression, followed by the suppression of c-Myc-dependent target genes. Treatments of UM cell lines with JQ1 showed that the Gnaq/Gna11 mutant cells were the most sensitive to BET inhibition with induction of cell death, while the cells without the mutations underwent cell cycle arrest in G1. Microarray analysis of UM cells revealed that several genes were differentially regulated by JQ1 treatment in Gnaq/11 mutant cells, with the downregulation of c-Myc, of the anti-apoptotic protein Bcl-2, and DNA repair proteins Rad51 and Brca1. While depletion of each of these genes did not affect cell viability, the concomitant silencing of Rad51 and Bcl-2 represented the minimal requirement to mimic the apoptotic effects of JQ1. As opposed to hematopoietic cancer cell lines, c-Myc depletion did not seem to play a major role in inhibiting the growth of these cells. Furthermore, the treatment with JQ1 resulted in significant antitumor activity in a mouse xenograft model of uveal melanoma with Gnaq mutation. Our results suggest the potential therapeutic use of BET bromodomain inhibitors for treating uveal melanoma with Gnaq/Gna11 mutations. Citation Format: Grazia Ambrosini. Differential effects of BRD4 inhibition on uveal melanoma cells with Gnaq/11 mutations. [abstract]. In: Proceedings of the AACR Special Conference on Advances in Melanoma: From Biology to Therapy; Sep 20-23, 2014; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(14 Suppl):Abstract nr B29." @default.
- W1596286866 created "2016-06-24" @default.
- W1596286866 creator A5026962347 @default.
- W1596286866 date "2015-07-15" @default.
- W1596286866 modified "2023-09-27" @default.
- W1596286866 title "Abstract B29: Differential effects of BRD4 inhibition on uveal melanoma cells with Gnaq/11 mutations" @default.
- W1596286866 doi "https://doi.org/10.1158/1538-7445.mel2014-b29" @default.
- W1596286866 hasPublicationYear "2015" @default.
- W1596286866 type Work @default.
- W1596286866 sameAs 1596286866 @default.
- W1596286866 citedByCount "0" @default.
- W1596286866 crossrefType "proceedings-article" @default.
- W1596286866 hasAuthorship W1596286866A5026962347 @default.
- W1596286866 hasConcept C104317684 @default.
- W1596286866 hasConcept C121608353 @default.
- W1596286866 hasConcept C143065580 @default.
- W1596286866 hasConcept C21790070 @default.
- W1596286866 hasConcept C2777658100 @default.
- W1596286866 hasConcept C2778502085 @default.
- W1596286866 hasConcept C2779176653 @default.
- W1596286866 hasConcept C2781018059 @default.
- W1596286866 hasConcept C2781187634 @default.
- W1596286866 hasConcept C29537977 @default.
- W1596286866 hasConcept C41091548 @default.
- W1596286866 hasConcept C501734568 @default.
- W1596286866 hasConcept C502942594 @default.
- W1596286866 hasConcept C54355233 @default.
- W1596286866 hasConcept C74401373 @default.
- W1596286866 hasConcept C81885089 @default.
- W1596286866 hasConcept C86803240 @default.
- W1596286866 hasConcept C97037327 @default.
- W1596286866 hasConceptScore W1596286866C104317684 @default.
- W1596286866 hasConceptScore W1596286866C121608353 @default.
- W1596286866 hasConceptScore W1596286866C143065580 @default.
- W1596286866 hasConceptScore W1596286866C21790070 @default.
- W1596286866 hasConceptScore W1596286866C2777658100 @default.
- W1596286866 hasConceptScore W1596286866C2778502085 @default.
- W1596286866 hasConceptScore W1596286866C2779176653 @default.
- W1596286866 hasConceptScore W1596286866C2781018059 @default.
- W1596286866 hasConceptScore W1596286866C2781187634 @default.
- W1596286866 hasConceptScore W1596286866C29537977 @default.
- W1596286866 hasConceptScore W1596286866C41091548 @default.
- W1596286866 hasConceptScore W1596286866C501734568 @default.
- W1596286866 hasConceptScore W1596286866C502942594 @default.
- W1596286866 hasConceptScore W1596286866C54355233 @default.
- W1596286866 hasConceptScore W1596286866C74401373 @default.
- W1596286866 hasConceptScore W1596286866C81885089 @default.
- W1596286866 hasConceptScore W1596286866C86803240 @default.
- W1596286866 hasConceptScore W1596286866C97037327 @default.
- W1596286866 hasLocation W15962868661 @default.
- W1596286866 hasOpenAccess W1596286866 @default.
- W1596286866 hasPrimaryLocation W15962868661 @default.
- W1596286866 hasRelatedWork W1503725263 @default.
- W1596286866 hasRelatedWork W2001213431 @default.
- W1596286866 hasRelatedWork W2023232785 @default.
- W1596286866 hasRelatedWork W2061117911 @default.
- W1596286866 hasRelatedWork W2117559539 @default.
- W1596286866 hasRelatedWork W2141202463 @default.
- W1596286866 hasRelatedWork W2265145264 @default.
- W1596286866 hasRelatedWork W2398150496 @default.
- W1596286866 hasRelatedWork W2561121817 @default.
- W1596286866 hasRelatedWork W2790987002 @default.
- W1596286866 hasRelatedWork W2791595469 @default.
- W1596286866 hasRelatedWork W2810085783 @default.
- W1596286866 hasRelatedWork W2896074158 @default.
- W1596286866 hasRelatedWork W2955039453 @default.
- W1596286866 hasRelatedWork W3004491023 @default.
- W1596286866 hasRelatedWork W3086373846 @default.
- W1596286866 hasRelatedWork W3096969380 @default.
- W1596286866 hasRelatedWork W3178919840 @default.
- W1596286866 hasRelatedWork W3179086529 @default.
- W1596286866 hasRelatedWork W3208082229 @default.
- W1596286866 isParatext "false" @default.
- W1596286866 isRetracted "false" @default.
- W1596286866 magId "1596286866" @default.
- W1596286866 workType "article" @default.